Home / Recalls / Medical Devices
Biomerieux Inc recalls ETEST CLINICAL CEFTOLOZANE/TAZO C/T US S30, CATALOG 414445
Recalled January 11, 2023 · FDA recall Z-0841-2023 · Biomerieux
Hazard
As the temperature and time out of range was exceeded, product performances cannot be guaranteed · FDA Class II
Units
6 units
Sold at
US Nationwide distribution.
Description
As the temperature and time out of range was exceeded, product performances cannot be guaranteed
Product
ETEST CLINICAL CEFTOLOZANE/TAZO C/T US S30, CATALOG 414445
Manufacturer(s)
Biomerieux Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →